XML 46 R39.htm IDEA: XBRL DOCUMENT
v3.21.4

RELATED PARTY TRANSACTIONS - Disclosure of expenses related to key management personnel (Details) - CAD ($) | 4 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2019 | Sep. 30, 2021 | Sep. 30, 2020
Disclosure of transactions between related parties [abstract] |  |  |
Professional fees | $ 0 | $ 87,074 | $ 22,575
Research and development | 0 | 772,596 | 26,777
Share-based compensation included in directors' compensation | 0 | 136,612 | 0
Share-based compensation included in professional fees | 0 | 23,126 | 0
Share-based compensation included in research and development | 0 | 236,652 | 161,300
Total expenses related to key management personnel | $ 0 | $ 1,256,060 | $ 210,652

X
- Definition The amount of compensation to key management personnel in the form of share-based payments included in Professional Fees. + References No definition available. + Details
Name: | drug_KeyManagementPersonnelCompensationShareBasedPaymentIncludedInProfessionalFees
Namespace Prefix: | drug_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of compensation to key management personnel in the form of share-based payments included in Research And Development. + References No definition available. + Details
Name: | drug_KeyManagementPersonnelCompensationShareBasedPaymentIncludedInResearchAndDevelopment
Namespace Prefix: | drug_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of compensation to key management personnel in the form of professional fees. + References No definition available. + Details
Name: | drug_KeyManagementPersonnelProfessionalFees
Namespace Prefix: | drug_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of compensation to key management personnel in the form of Research And Development. + References No definition available. + Details
Name: | drug_KeyManagementPersonnelResearchAndDevelopment
Namespace Prefix: | drug_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2020-01-01 -Paragraph 17 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2020-en-r&anchor=para_17&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_KeyManagementPersonnelCompensation
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2020-01-01 -Paragraph 17 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2020-en-r&anchor=para_17_e&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration